Clinical Research Directory
Browse clinical research sites, groups, and studies.
PT150 Drug for Use in Alcohol Use Disorder
Sponsor: Pop Test Oncology LLC
Summary
The goal of this study is to learn if PT150 can reduce the behavioral and physical effects of stress, alcohol, and alcohol use in people with alcohol use disorder.
Official title: Selective Glucocorticoid Receptor Antagonism in Alcohol Use Disorder: A Human Laboratory Study
Key Details
Gender
All
Age Range
21 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
34
Start Date
2025-02-01
Completion Date
2028-07-31
Last Updated
2025-05-22
Healthy Volunteers
No
Conditions
Interventions
alcohol
During the alcohol administration session participants will receive a single administration of alcohol (0.5 g/kg) mixed with lemon lime soda. Participants will consume the drink within 5 min.
Stress-Induction
The stress-induction procedure is the Cold Pressure Test \[CPT\]) stressor. The bilateral foot CPT requires participants to submerge both feet in ice-cold water (24°C) for 3 minutes.
PT150
Participants will ingest PT150 (0, 225, 450 mg) twice daily (e.g., 0800, 2000h) for 5 five days prior to the conduct of the experimental sessions. The sequence of PT150 doses will be quasi-random such that participants will be maintained on the lower dose of PT150 (i.e., 225 mg twice/day) before the higher dose.
Locations (1)
University of Kentucky
Lexington, Kentucky, United States